| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/C2MB25298H |
| P698 | PubMed publication ID | 23064179 |
| P50 | author | Charles Theillet | Q55664894 |
| P2093 | author name string | Charles-Henri Lecellier | |
| Guillaume Vetter | |||
| Anne Saumet | |||
| Etienne Antoine | |||
| Manuella Bouttier | |||
| Christine Roubert | |||
| Beatrice Orsetti | |||
| P2860 | cites work | MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU | Q21136391 |
| Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer | Q24295934 | ||
| Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| Polyadenylation of ribosomal RNA in human cells | Q24546450 | ||
| MicroRNA genes are transcribed by RNA polymerase II | Q24562649 | ||
| miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity | Q24595376 | ||
| miRTarBase: a database curates experimentally validated microRNA-target interactions | Q24613026 | ||
| MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1) | Q24617676 | ||
| Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs | Q24631037 | ||
| miRGen 2.0: a database of microRNA genomic information and regulation | Q24644535 | ||
| MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype | Q24646090 | ||
| MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2 | Q24655427 | ||
| miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements | Q24656666 | ||
| A microRNA signature of hypoxia | Q24681599 | ||
| Mammalian microRNAs predominantly act to decrease target mRNA levels | Q27860535 | ||
| A microRNA polycistron as a potential human oncogene | Q27860720 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation | Q28254300 | ||
| De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures | Q28277249 | ||
| Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92 | Q28294917 | ||
| Reactome: a database of reactions, pathways and biological processes | Q28298042 | ||
| Gene silencing by microRNAs: contributions of translational repression and mRNA decay | Q29615825 | ||
| c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 | ||
| A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis | Q29619201 | ||
| PAZAR: a framework for collection and dissemination of cis-regulatory sequence annotation | Q30483578 | ||
| IDconverter and IDClight: conversion and annotation of gene and protein IDs. | Q33268779 | ||
| Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations | Q33284802 | ||
| Upregulation of miR-23a-27a-24-2 cluster induces caspase-dependent and -independent apoptosis in human embryonic kidney cells | Q33464974 | ||
| TransmiR: a transcription factor-microRNA regulation database | Q33600597 | ||
| MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model | Q33837392 | ||
| The role of incoherent microRNA-mediated feedforward loops in noise buffering | Q33851558 | ||
| Role of hormones in mammary cancer initiation and progression | Q33923682 | ||
| Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression | Q34117250 | ||
| Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets | Q34537141 | ||
| Concordance among gene-expression-based predictors for breast cancer | Q34555829 | ||
| Real-time imaging of cotranscriptional splicing reveals a kinetic model that reduces noise: implications for alternative splicing regulation | Q35018262 | ||
| miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention. | Q35559007 | ||
| Nuclear retinoid receptors and the transcription of retinoid-target genes | Q35690779 | ||
| Tumor cell metabolism: an integral view. | Q35760954 | ||
| Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer | Q35782978 | ||
| How retinoids regulate breast cancer cell proliferation and apoptosis | Q35805457 | ||
| A refined molecular taxonomy of breast cancer | Q35838290 | ||
| Roles for microRNAs in conferring robustness to biological processes | Q35955737 | ||
| Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. | Q36028691 | ||
| Chemoprevention of hormone receptor-negative breast cancer: new approaches needed | Q36153371 | ||
| Estradiol-regulated microRNAs control estradiol response in breast cancer cells | Q37298620 | ||
| The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. | Q37354147 | ||
| MYC-induced cancer cell energy metabolism and therapeutic opportunities | Q37438881 | ||
| Meta-regulation: microRNA regulation of glucose and lipid metabolism | Q37607525 | ||
| Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene | Q37684502 | ||
| Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree? | Q37715518 | ||
| MicroRNAs in the pathogenesis of cancer | Q37956072 | ||
| MicroRNAs: toward the clinic for breast cancer patients | Q37956073 | ||
| miR-210: the master hypoxamir | Q37968614 | ||
| LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis | Q39567937 | ||
| Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells | Q39721370 | ||
| Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer | Q39800540 | ||
| Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia | Q39926860 | ||
| Early mitochondrial alterations in ATRA-induced cell death | Q40400306 | ||
| Alterations in cellular retinol metabolism contribute to differential retinoid responsiveness in normal human mammary epithelial cells versus breast cancer cells | Q40728517 | ||
| Effects of retinoic acid isomers on apoptosis and enzymatic antioxidant system in human breast cancer cells | Q42002274 | ||
| Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth | Q43262197 | ||
| Prediction of nuclear hormone receptor response elements. | Q51983592 | ||
| "Micro"-management of DNA repair genes by hypoxia. | Q53357273 | ||
| P433 | issue | 12 | |
| P921 | main subject | tretinoin | Q29417 |
| microRNA | Q310899 | ||
| P304 | page(s) | 3242-3253 | |
| P577 | publication date | 2012-10-01 | |
| P1433 | published in | Molecular BioSystems | Q3319467 |
| P1476 | title | Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells | |
| P478 | volume | 8 |
| Q46458100 | Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer. |
| Q33755908 | Cancer stem cell theory and the warburg effect, two sides of the same coin? |
| Q58133737 | Expression and regulation of Angiopoietins and their receptor Tie-2 in sika deer antler |
| Q92494564 | Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells |
| Q87020885 | In silico analysis of pathways affected by differentially expressed microRNA in adrenocortical tumors |
| Q28397240 | Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features |
| Q34612130 | MiR-23a facilitates the replication of HSV-1 through the suppression of interferon regulatory factor 1. |
| Q35955244 | MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells |
| Q64064359 | MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines |
| Q34549827 | MicroRNAs in lupus |
| Q64234430 | Micromanaging aerobic respiration and glycolysis in cancer cells |
| Q96609205 | Noncoding RNAs: the shot callers in tumor immune escape |
| Q36012406 | Relationship between Carotenoids, Retinol, and Estradiol Levels in Older Women |
| Q37681192 | Spatiotemporal Analysis of a Glycolytic Activity Gradient Linked to Mouse Embryo Mesoderm Development. |
| Q34177547 | The potential of microRNAs in personalized medicine against cancers |
| Q35912303 | miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. |
| Q90706419 | microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance |
| Q38668239 | microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers |
Search more.